Skip to content

Clinical trials

Phase 3 Rectal Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 3 Country / region: Taiwan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20101
20201
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital2
Amgen1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
Novartis1
Novartis Pharmaceuticals1
Pfizer1
Shih-Kai Hung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms9
Colonic Neoplasms6
Colorectal Neoplasms6
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1
Hyperthermia1
Intestinal Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.